We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Spectrum Pharmaceuticals Inc | NASDAQ:SPPI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.03 | 1.14 | 0.9785 | 0 | 01:00:00 |
From May 2019 to May 2024
On November 17, 2015, TheGrantLawFirm, PLLC disseminated a notice to shareholders under the PSLRA, announcing that it filed a class action complaint (“Complaint”) on behalf of all securities holders who purchased securities of Spectrum Pharmaceuticals, Inc. (SPPI: NASDAQ)(“Spectrum” or the “Company”) during the period between May 7, 2015 until October 23, 2015, inclusive (the “Class Period”). Since the publication of the PSLRA notice, TheGrantLawFirm, PPLC has withdrawn the complaint.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151215006585/en/
TheGrantLawFirm, PLLCLynda J. Grant, Esq.Telephone: 212-292-4441Facsimile: 212-292-4446lgrant@grantfirm.com
1 Year Spectrum Pharmaceuticals Chart |
1 Month Spectrum Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
